Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial Randomized trials had shown that rituximab maintenance (RM) ...
Objective: The purpose of this paper was to provide an introductory tutorial on when and what to do when using control systems engineering for designing and optimizing adaptive mobile health (mHealth) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results